Safety first: Tracking adverse events associated with new therapies for people with hemophilia

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)3-5
Number of pages3
JournalJournal of Thrombosis and Haemostasis
Volume19
Issue numberS1
DOIs
StatePublished - Jan 2021

Keywords

  • clinical research
  • emicizumab
  • hemophilia
  • mortality
  • registry

ASJC Scopus subject areas

  • Hematology

Cite this